Recursion, Novavax and Crispr Stocks Trending in Pre-Market—Here's Why
Recursion, Novavax and Crispr Therapeutics slip in premarket trading after surging Wednesday on positive cancer therapy trial results.
Read original at benzingaStocks · News reference
Novavax Stock Rallies Tuesday: What's Happening?
Shares of Novavax are trading higher Tuesday morning as buying interest continues across late-stage vaccine developers.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 25, 2026, 3:31 PM
- Checked
- Aug 25, 2026, 3:31 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Novavax Stock Moves Higher Wednesday: What's Driving the Action?
Shares of Novavax Inc (NASDAQ: NVAX) are trading higher Wednesday. The move comes as a major clinical victory in the oncology space generated widespread momentum across vaccine developers.
Read original at benzingaTrump Says Administration Recognizing Childhood Vaccine Recommendations For Only 11 Core Vaccinations; Hepatitis B, COVID-19, Influenza No Longer Recommended For All Children
https://youtu.be/H_RititNE8U
Read original at benzinga